Advertisement
Screener

VolitionRx Limited (VNRX) Deferred Income Tax Expense (Benefit)

2.6 / 5 stars · 32/62 Roast Me

VolitionRx Limited Deferred Income Tax Expense (Benefit)

VolitionRx Limited (VNRX) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.

Financial Statements › Cash Flow › Operating Activities

us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-31

  • VolitionRx Limited deferred income tax expense (benefit) for the quarter ending 2015-12-31 was $0.00.
  • VolitionRx Limited deferred income tax expense (benefit) for the quarter ending 2015-09-30 was -$640.00.
  • VolitionRx Limited deferred income tax expense (benefit) for fiscal 2025 was $0.00.
  • VolitionRx Limited deferred income tax expense (benefit) for fiscal 2024 was $0.00.
  • VolitionRx Limited deferred income tax expense (benefit) for fiscal 2015 was $48.19K.
Period endDeferred Income Tax Expense (Benefit) 3 monthDeferred Income Tax Expense (Benefit) 6 monthDeferred Income Tax Expense (Benefit) 9 monthDeferred Income Tax Expense (Benefit) 12 month
2025-12-31$0.00
10-K · filed 2026-03-31
2024-12-31$0.00
10-K · filed 2026-03-31
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11
-$640.00
derived: sum of 2 quarters · filed 2016-03-11
$48.19K
10-K · filed 2016-03-11
2015-09-30-$640.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$48.19K
10-Q · filed 2015-11-04
2015-06-30$48.83K
10-Q · filed 2015-08-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92